Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 TherapyTonino Alonzi, Delia Goletti, Roberta Nardacci et al.|Cells|2021Cited by 17
Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variantsTonino Alonzi, Delia Goletti, Alessandra Aiello et al.|Cell Death Discovery|2022Cited by 17
Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseasesTonino Alonzi, Delia Goletti, Mauro Piacentini et al.|Biomedicine & Pharmacotherapy|2024Cited by 6